Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TUMOR VASCULATURE

  • Read more about COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TUMOR VASCULATURE
US Application 62/009,369
Filed on 2014-06-09

Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses

  • Read more about Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses
US Application 62/026,221
Filed on 2014-07-18

Compounds that Bind to Human Immunodeficiency Virus Rev Response Element

  • Read more about Compounds that Bind to Human Immunodeficiency Virus Rev Response Element
US Application 61/934,379
Filed on 2014-01-31

Methods For Producing Autologous T Cells Useful To Treat B Cell Malignancies And Other Cancers

  • Read more about Methods For Producing Autologous T Cells Useful To Treat B Cell Malignancies And Other Cancers
US Application 61/935,833
Filed on 2014-02-04

HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR 5T4 AND METHODS OF THEIR USE

  • Read more about HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR 5T4 AND METHODS OF THEIR USE
US Application 62/034,995
Filed on 2014-08-08

Combination Of Griffithsin With Other Substances To Make A Product For The Prevention Of STD

  • Read more about Combination Of Griffithsin With Other Substances To Make A Product For The Prevention Of STD
US Application 61/932,706
Filed on 2014-01-28

PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO

  • Read more about PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO
US Application 62/034,990
Filed on 2014-08-08

Triggering RNA Interference With RNA, RNA-DNA And DNA-RNA Nanoparticles

  • Read more about Triggering RNA Interference With RNA, RNA-DNA And DNA-RNA Nanoparticles
US Application 61/990,094
Filed on 2014-05-07

Polyketal Nanoparticles Including A CPG Oligodeoxynucleotide For The Treatment of Lung Cancer

  • Read more about Polyketal Nanoparticles Including A CPG Oligodeoxynucleotide For The Treatment of Lung Cancer
US Application 62/024,657
Filed on 2014-07-15

Detection Of Colorectal Cancer With Two Novel Heme-Related Molecules In Human Feces

  • Read more about Detection Of Colorectal Cancer With Two Novel Heme-Related Molecules In Human Feces
US Application 62/019,258
Filed on 2014-06-30

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 94
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • Page 99
  • Page 100
  • Page 101
  • Page 102
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health